Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of VR game-based brain function activation with or without autologous bone marrow mononuclear cell transplantation
jRCT1030260431Recruiting
- Start
- Sep 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label trial of autologous bone marrow-derived mononuclear cell in Dementia and brain infarction (3 arms), sponsored by none. Primary endpoints: Change in ADAS-Cog11 score and Change in FMA score. Started Sep 2026; status: recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
Dementiabrain infarction
Beyond the preview
Go deeper on jRCT1030260431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260431.